SCHEMBL25920578

SCHEMBL25920578

C=c1c(=C)n(C)c2c(F)cccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 2/20 0.41
▸ BTK Q06187 2/20 0.41
▸ TSHR P16473 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ PCSK9 Q8NBP7 1/20 0.33
▸ PLK1 P53350 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ DAO P14920 1/20 0.33
▸ ICMT O60725 1/20 0.32
▸ ALKBH5 Q6P6C2 1/20 0.32
▸ FTO Q9C0B1 1/20 0.32
▸ KAT2B Q92831 1/20 0.31
▸ BRD4 O60885 1/20 0.31
▸ GPR3 P46089 1/20 0.31
▸ GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21311183 0.71 ALKBH5 (0.63) JAK2BTKTSHRKDM4ELMNA
SCHEMBL29785322 0.69 ADORA3 (0.46) JAK2BTKLMNAMAPK1ALDH1A1
SCHEMBL3580909 0.69 JAK2 (0.42) JAK2BTKTSHRKDM4ELMNA
SCHEMBL24050350 0.67 GPR3 (0.58) KDM4ELMNAHTTHSD17B10ALDH1A1
SCHEMBL11331884 0.64 NPC1 (0.47) JAK2BTKKDM4ELMNAALDH1A1
SCHEMBL7295311 0.64 JAK2 (0.42) JAK2BTKKDM4ELMNAMAPK1
SCHEMBL7285389 0.64 JAK2 (0.38) JAK2BTKKDM4EPLK1ALDH1A1
SCHEMBL11066610 0.63 CHRM1 (0.40) JAK2BTKTSHRKDM4ELMNA
SCHEMBL28064638 0.63 MCL1 (0.47) JAK2BTKTSHRKDM4ENPC1
SCHEMBL23410172 0.63 ALDH1A1 (0.41) JAK2BTKTSHRKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 — — WO disclosed
Send feedback